Trial intelligence / Profile preview

Effect of dexmedetomidine on arterial lactate levels at the end of laparoscopic major hepatectomy

TCTR20251222015Phase 4Not yet recruiting

Sponsor
King Chulalongkorn Memorial Hospital
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in surgical stress (2 arms), sponsored by King Chulalongkorn Memorial Hospital. Primary endpoint: Arterial lactate level at end of surgery. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

surgical stress

Beyond the preview

Go deeper on TCTR20251222015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20251222015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call